Disorder Name: Disorders due to use of non-psychoactive substances
Disorder Code: 247116319
Code Range: Not specified
Class Kind: category

Standard Definition:
Disorders due to use of non-psychoactive substances are characterised by the pattern and consequences of non-medical use of non-psychoactive substances. Non-psychoactive substances include laxatives, anabolic steroids, growth hormone, erythropoietin, and non-steroidal anti-inflammatory drugs. They may also include proprietary or over-the-counter medicines and folk remedies. Non-medical use of these substances may be associated with harm to the individual due to the direct or secondary toxic effects of the non-psychoactive substance on body organs and systems, or a harmful route of administration (e.g., infections due to intravenous self-administration). They are not associated with intoxication or with a dependence or withdrawal syndrome and are not recognized causes of substance-induced mental disorders.

Clinical Description and Diagnostic Guidelines:
Clinical Description:
Disorders due to use of non-psychoactive substances are characterised by the pattern and consequences of non-medical use of non-psychoactive substances. Non-psychoactive substances include laxatives, anabolic steroids, growth hormone, erythropoietin, and non-steroidal anti-inflammatory drugs. They may also include proprietary or over-the-counter medicines and folk remedies. Non-medical use of these substances may be associated with harm to the individual due to the direct or secondary toxic effects of the non-psychoactive substance on body organs and systems, or a harmful route of administration (e.g., infections due to intravenous self-administration). They are not associated with intoxication or with a dependence or withdrawal syndrome and are not recognized causes of substance-induced mental disorders.

Diagnostic Guidelines:
• Symptom assessment should be conducted within appropriate time frames
• Consider impact of symptoms on personal, family, social, and occupational functioning
• Evaluate symptom severity and duration
• Rule out symptoms due to substance use, medical conditions, or other psychological disorders
• Recommend use of standardized assessment tools and diagnostic criteria

Treatment Considerations:
• Develop individualized treatment plans
• Consider evidence-based treatment approaches
• Refer to specialist treatment when necessary
• Regular monitoring of treatment progress and plan adjustments

For more detailed clinical guidelines, please refer to official ICD-11 documentation.